Variant report
Variant | esv3429463 |
---|---|
Chromosome Location | chr6:29764673-29767271 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:34)
- CpG islands (count:122)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:34 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:29764856-29765271 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr6:29765080-29765230 | RPTEC | kidney: | n/a | n/a |
3 | E2F4 | chr6:29764847-29765445 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | EP300 | chr6:29764905-29765219 | Hela-S3 | cervix: | n/a | n/a |
5 | FOS | chr6:29764566-29765479 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr6:29764833-29765396 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr6:29764602-29765459 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr6:29764624-29765292 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOSL1 | chr6:29764773-29765365 | HCT-116 | colon: | n/a | n/a |
10 | GTF2F1 | chr6:29764868-29765271 | Hela-S3 | cervix: | n/a | n/a |
11 | MAFF | chr6:29764913-29765126 | HepG2 | liver: | n/a | chr6:29765033-29765051 |
12 | MAFK | chr6:29764926-29765184 | HepG2 | liver: | n/a | chr6:29765035-29765050 |
13 | MAFK | chr6:29764900-29765183 | IMR90 | lung: | n/a | chr6:29765035-29765050 |
14 | MAFK | chr6:29764904-29765223 | Hela-S3 | cervix: | n/a | chr6:29765035-29765050 |
15 | MAFK | chr6:29764916-29765116 | HepG2 | liver: | n/a | chr6:29765035-29765050 |
16 | MAX | chr6:29764965-29765409 | Hela-S3 | cervix: | n/a | n/a |
17 | MYC | chr6:29764922-29765277 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | MYC | chr6:29764850-29765434 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr6:29766632-29766749 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr6:29766114-29766275 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr6:29764905-29765031 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr6:29765780-29765860 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr6:29765025-29765525 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | RFX5 | chr6:29765012-29765146 | Hela-S3 | cervix: | n/a | n/a |
25 | SETDB1 | chr6:29765012-29765485 | U2OS | brain: | n/a | n/a |
26 | SMC3 | chr6:29764919-29765204 | Hela-S3 | cervix: | n/a | n/a |
27 | STAT3 | chr6:29764727-29765522 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr6:29764807-29765196 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | STAT3 | chr6:29764741-29765296 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | STAT3 | chr6:29764733-29765461 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | STAT3 | chr6:29764808-29765514 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | TBP | chr6:29764996-29765253 | Hela-S3 | cervix: | n/a | n/a |
33 | USF2 | chr6:29765006-29765406 | Hela-S3 | cervix: | n/a | chr6:29765170-29765181 |
34 | ZKSCAN1 | chr6:29765020-29765406 | Hela-S3 | cervix: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29766061-29766111 | SAEC | small airway: | n/a |
2 | chr6:29766061-29766111 | A549 | lung: | n/a |
3 | chr6:29766061-29766111 | NHDF-neo | bronchial: | n/a |
4 | chr6:29765324-29765374 | AG09309 | skin: | n/a |
5 | chr6:29765324-29765374 | U87 | brain: | n/a |
6 | chr6:29765324-29765374 | BE2_C | brain: | n/a |
7 | chr6:29765324-29765374 | SAEC | small airway: | n/a |
8 | chr6:29765324-29765374 | H1-hESC | embryonic stem cell: | embryo |
9 | chr6:29766061-29766111 | AG09319 | gingival: | n/a |
10 | chr6:29765324-29765374 | SKMC | muscle: | n/a |
11 | chr6:29765324-29765374 | PrEC | prostate: | n/a |
12 | chr6:29765324-29765374 | PFSK-1 | brain: | n/a |
13 | chr6:29766061-29766111 | HRE | kidney: | n/a |
14 | chr6:29766061-29766111 | H1-hESC | embryonic stem cell: | embryo |
15 | chr6:29765324-29765374 | SK-N-MC | brain: | n/a |
16 | chr6:29766061-29766111 | HNPCEpiC | eye: | n/a |
17 | chr6:29765324-29765374 | HepG2 | liver: | n/a |
18 | chr6:29765324-29765374 | AG10803 | skin: | n/a |
19 | chr6:29765324-29765374 | HEK293 | kidney: | embryo |
20 | chr6:29766061-29766111 | AG04450 | lung: | fetal |
21 | chr6:29766061-29766111 | SK-N-MC | brain: | n/a |
22 | chr6:29765324-29765374 | ovcar-3 | ovarian: | n/a |
23 | chr6:29766061-29766111 | HIPEpiC | eye: | n/a |
24 | chr6:29765324-29765374 | NB4 | blood: | n/a |
25 | chr6:29766061-29766111 | AoSMC | blood vessel: | n/a |
26 | chr6:29765324-29765374 | HRCEpiC | kidney: | n/a |
27 | chr6:29765324-29765374 | HCPEpiC | choroid plexus: | n/a |
28 | chr6:29765324-29765374 | A549 | lung: | n/a |
29 | chr6:29765324-29765374 | LNCaP | prostate: | n/a |
30 | chr6:29765324-29765374 | T-47D | breast: | n/a |
31 | chr6:29766061-29766111 | HEK293 | kidney: | embryo |
32 | chr6:29765324-29765374 | Jurkat | blood: | n/a |
33 | chr6:29766061-29766111 | HL-60 | blood: | n/a |
34 | chr6:29766061-29766111 | T-47D | breast: | n/a |
35 | chr6:29765324-29765374 | NH-A | brain: | n/a |
36 | chr6:29766061-29766111 | GM12878 | blood: | n/a |
37 | chr6:29765324-29765374 | SK-N-SH_RA | brain: | n/a |
38 | chr6:29765324-29765374 | MCF10A-Er-Src | breast: | n/a |
39 | chr6:29765324-29765374 | GM12891 | blood: | n/a |
40 | chr6:29766061-29766111 | ovcar-3 | ovarian: | n/a |
41 | chr6:29765324-29765374 | Caco-2 | colon: | n/a |
42 | chr6:29765324-29765374 | AG09319 | gingival: | n/a |
43 | chr6:29765324-29765374 | AG04449 | skin: | fetal |
44 | chr6:29766061-29766111 | PrEC | prostate: | n/a |
45 | chr6:29765324-29765374 | SK-N-SH | brain: | n/a |
46 | chr6:29766061-29766111 | NB4 | blood: | n/a |
47 | chr6:29765324-29765374 | GM12878 | blood: | n/a |
48 | chr6:29766061-29766111 | HEEpiC | esophagus: | n/a |
49 | chr6:29766061-29766111 | HCM | heart: | n/a |
50 | chr6:29766061-29766111 | IMR90 | lung: | fetal |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29764068..29767781-chr6:29769569..29773130,4 | K562 | blood: | |
2 | chr6:29764926..29767618-chr6:29920990..29923179,3 | MCF-7 | breast: | |
3 | chr6:29760049..29761986-chr6:29763646..29765387,2 | K562 | blood: | |
4 | chr6:29763208..29764709-chr6:29776682..29778485,2 | MCF-7 | breast: | |
5 | chr6:29762168..29764765-chr6:29782319..29784097,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
HCG4 | TF binding region |
HLA-P | TF binding region |
HCG4 | CpG island |
HLA-P | CpG island |
ENSG00000213880 | chromatin interactions |
ENSG00000176998 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114974700 | chr6:29764674-29764675 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs182443579 | chr6:29764680-29764681 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs567454009 | chr6:29764706-29764707 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs11751282 | chr6:29764707-29764708 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs554536416 | chr6:29764724-29764725 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs1633003 | chr6:29764759-29764760 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs370244978 | chr6:29764780-29764781 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs376963347 | chr6:29764781-29764782 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs199870582 | chr6:29764788-29764789 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs116330963 | chr6:29764803-29764804 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs538371680 | chr6:29764835-29764836 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs200904789 | chr6:29764867-29764868 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs201677549 | chr6:29764871-29764872 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs199890514 | chr6:29764873-29764874 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs201189719 | chr6:29764902-29764903 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs557912877 | chr6:29764910-29764911 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs571547442 | chr6:29764933-29764934 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs114286588 | chr6:29764938-29764939 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs116830057 | chr6:29764939-29764940 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs201031704 | chr6:29764955-29764956 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs537339602 | chr6:29764966-29764967 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs114384197 | chr6:29764968-29764969 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs73403743 | chr6:29764971-29764972 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs115323178 | chr6:29764978-29764979 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs200449506 | chr6:29764995-29764996 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs201620663 | chr6:29764996-29764997 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs73747518 | chr6:29764998-29764999 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs1630969 | chr6:29765001-29765002 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs9468622 | chr6:29765003-29765004 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs559269476 | chr6:29765013-29765014 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs374688218 | chr6:29765019-29765020 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs9468623 | chr6:29765020-29765021 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs1633002 | chr6:29765047-29765048 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs75904618 | chr6:29765055-29765056 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs75220593 | chr6:29765061-29765062 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs201094801 | chr6:29765077-29765078 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs368324812 | chr6:29765078-29765079 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs575350796 | chr6:29765082-29765083 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs2523414 | chr6:29765087-29765088 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs561205088 | chr6:29765117-29765118 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs369430766 | chr6:29765120-29765121 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs146761539 | chr6:29765123-29765124 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs372101546 | chr6:29765142-29765143 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs72507839 | chr6:29765145-29765146 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs369067188 | chr6:29765148-29765149 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs559749707 | chr6:29765155-29765156 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs532066809 | chr6:29765162-29765163 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs200298173 | chr6:29765168-29765169 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs73747522 | chr6:29765240-29765241 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs150403972 | chr6:29765257-29765258 | Enhancers Weak transcription Bivalent Enhancer | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29761000-29765200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr6:29761800-29766200 | Weak transcription | Pancreas | Pancrea |
3 | chr6:29763800-29764800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:29763800-29766000 | Enhancers | HMEC | breast |
5 | chr6:29763800-29766200 | Enhancers | NHEK | skin |
6 | chr6:29763800-29766800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr6:29764000-29766000 | Enhancers | NHDF-Ad | bronchial |
8 | chr6:29764400-29764800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr6:29764400-29765400 | Enhancers | Hela-S3 | cervix |
10 | chr6:29764600-29766200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr6:29764800-29780600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr6:29765000-29765400 | Bivalent Enhancer | Muscle Satellite Cultured Cells | -- |
13 | chr6:29765000-29765400 | Enhancers | Stomach Mucosa | stomach |
14 | chr6:29765200-29765600 | Enhancers | NH-A | brain |
15 | chr6:29765200-29765800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr6:29765800-29766200 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin03 | Skin |